These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19715781)

  • 21. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
    Melegaro A; Edmunds WJ
    Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?
    Mangen MJ; van Duynhoven YT; Vennema H; van Pelt W; Havelaar AH; de Melker HE
    Vaccine; 2010 Mar; 28(14):2624-35. PubMed ID: 20109593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An economic analysis of rotavirus vaccination in Italy.
    Giammanco MD; Coniglio MA; Pignato S; Giammanco G
    Vaccine; 2009 Jun; 27(29):3904-11. PubMed ID: 19446934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of rotavirus vaccination in Australia.
    Newall AT; Beutels P; Macartney K; Wood J; MacIntyre CR
    Vaccine; 2007 Dec; 25(52):8851-60. PubMed ID: 18022735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK.
    Martin A; Batty A; Roberts JA; Standaert B
    Vaccine; 2009 Jul; 27(33):4520-8. PubMed ID: 19446594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq.
    Weycker D; Sofrygin O; Kemner JE; Pelton SI; Oster G
    Vaccine; 2009 Aug; 27(36):4930-7. PubMed ID: 19555715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease.
    Harris JP; Jit M; Cooper D; Edmunds WJ
    Vaccine; 2007 May; 25(20):3962-70. PubMed ID: 17395343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report of the 'European Expert Meeting on Rotavirus Vaccination', Tampere, Finland, 19-20 May 2009.
    Vesikari T; Sutherland D; Jackson AE
    Vaccine; 2009 Dec; 27(52):7222-7. PubMed ID: 19822233
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
    Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
    Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
    Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
    J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya.
    Tate JE; Rheingans RD; O'Reilly CE; Obonyo B; Burton DC; Tornheim JA; Adazu K; Jaron P; Ochieng B; Kerin T; Calhoun L; Hamel M; Laserson K; Breiman RF; Feikin DR; Mintz ED; Widdowson MA
    J Infect Dis; 2009 Nov; 200 Suppl 1():S76-84. PubMed ID: 19817618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost and cost-effectiveness of childhood vaccination against rotavirus in France.
    Melliez H; Levybruhl D; Boelle PY; Dervaux B; Baron S; Yazdanpanah Y
    Vaccine; 2008 Jan; 26(5):706-15. PubMed ID: 18166250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China.
    Liu N; Yen C; Fang ZY; Tate JE; Jiang B; Parashar UD; Zeng G; Duan ZJ
    Vaccine; 2012 Nov; 30(48):6940-5. PubMed ID: 22705174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of Rotavirus vaccination in Vietnam.
    Kim SY; Goldie SJ; Salomon JA
    BMC Public Health; 2009 Jan; 9():29. PubMed ID: 19159483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation of a routine rotavirus vaccination programme in Indonesia.
    Wilopo SA; Kilgore P; Kosen S; Soenarto Y; Aminah S; Cahyono A; Ulfa M; Tholib A
    Vaccine; 2009 Nov; 27 Suppl 5():F67-74. PubMed ID: 19931723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conclusion on cost-effectiveness of rotavirus vaccination highly dependent on assumptions.
    Goossens L; Standaert B; Hartwig N; Hövels AM; Al MJ
    Vaccine; 2009 Apr; 27(19):2531-2. PubMed ID: 19428858
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
    Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness evaluation of a rotavirus vaccination program in Argentina.
    Martí SG; Alcaraz A; Valanzasca P; McMullen M; Standaert B; Garay U; Lepetic A; Gomez J
    Vaccine; 2015 Oct; 33(42):5684-5690. PubMed ID: 26303875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
    Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
    Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cost of vaccination and cost of sick leave are determinants of cost-effectiveness vaccination against rotavirus].
    Gyrd-Hansen D; Olsen KR
    Ugeskr Laeger; 2012 Feb; 174(8):480-3. PubMed ID: 22348668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.